An interactive tool to explore clinical trial data
Recent articles
Autism Drug Trial Tracker
Explore hundreds of clinical trials with our interactive tool.
![](https://www.thetransmitter.org/wp-content/uploads/2021/12/DrugTrackerTool844.jpg)
Autism Drug Trial Tracker
Explore hundreds of clinical trials with our interactive tool.
Introducing Spectrum’s Autism Drug Trial Tracker
The tool provides interactive, curated information on more than 200 clinical trials for autism and related conditions.
![Control panel made with pills as buttons and switches.](https://www.thetransmitter.org/wp-content/uploads/2021/12/AboutTracker844.jpg)
Introducing Spectrum’s Autism Drug Trial Tracker
The tool provides interactive, curated information on more than 200 clinical trials for autism and related conditions.
Autism Drug Trial Tracker: User Guide
Learn how to use the Autism Drug Trial Tracker, with specific examples and detailed explanations for each data column.
![](https://www.thetransmitter.org/wp-content/uploads/2021/12/DriugTrackerHowTo-844.jpg)
Autism Drug Trial Tracker: User Guide
Learn how to use the Autism Drug Trial Tracker, with specific examples and detailed explanations for each data column.
Explore more from The Transmitter
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
![](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200_coughingmice-1024x720.webp)
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
![Capitol building](https://www.thetransmitter.org/wp-content/uploads/2024/09/capitolhill-1200-1024x692.webp)
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
![Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200-ketamine-receptor-transmitter-neuroscience-1024x683.webp)
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.